Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MESA LABORATORIES INC /CO/ Director's Dealing 2022

Aug 17, 2022

33153_dirs_2022-08-17_95551b42-f200-4854-b61e-6d70fdc6642d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: MESA LABORATORIES INC /CO/ (MLAB)
CIK: 0000724004
Period of Report: 2022-08-15

Reporting Person: Sakys John (CFO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-08-15 Common Stock M 628 $70.56 Acquired 9306 Direct
2022-08-16 Common Stock M 1372 $70.56 Acquired 10678 Direct
2022-08-15 Common Stock S 628 $200.54 Acquired 10050 Direct
2022-08-16 Common Stock S 1372 $200.58 Disposed 8678 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-08-15 Non Qualified Stock Option $70.56 X 628 Disposed 2023-04-01 Common Stock (628) Direct
2022-08-16 Non Qualified Stock Option $70.56 X 1372 Disposed 2023-04-01 Common Stock (1372) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 100 Indirect

Footnotes

F1: 1/7 exercisable on each anniversary of the 04/01/2015 grant date

F2: Sale reported on this Form 4 was effected pursuant to a Rule 10B5-1 trading plan, adopted by the reporting person on June 14, 2022

F3: Consists of 100 shares held by children of which Mr. Sakys is custodian